Circle CVI joins EXIT-CVD research consortium to advance imaging-informed, personalized cardiovascular care across Europe
Financial Post ·
Five-year research project unites 42 public and private partners across 17 countries to conduct 22 clinical studies involving 14,000+ patients; first patients will be enrolled this month Project aims to help cardiac patients avoid deterioration through early, personalized interventions delivered across the cardiac care journey Interventions will be co-created with patients and designed to systematically […]
CALGARY, Alberta, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Circle Cardiovascular Imaging (Circle CVI), a provider of AI-enabled cardiovascular imaging software, today announced its participation in EXIT-CVD , a five-year research project bringing together 42 public and private partners across 17 countries. Co-funded by the European Union’s Innovative Health Initiative ( IHI ) and industry partners, the consortium is led by University Medical Center Groningen ( UMCG ) and Philips and aims to transform how cardiovascular disease is detected, monitored and treated. The project will conduct 22 clinical studies involving more than 14,000 patients, investigating opportunities to prevent disease before it develops, reverse disease progression or halt deterioration in advanced disease. Patient enrollment for the first studies is scheduled to begin in October 2026. Read More